Antiviral activity of (+)-sattabacin against varicella zoster
- PMID: 23219702
- PMCID: PMC8801122
- DOI: 10.1016/j.bmcl.2012.11.017
Antiviral activity of (+)-sattabacin against varicella zoster
Abstract
The first report of the antiviral activity of (+)-sattabacin against varicella-zoster virus (VZV) is described. Our results show that (+)-sattabacin potently inhibits the growth of VZV at concentrations in the range of other drugs commonly prescribed for VZV infection. Experiments detailing the synthesis of (+)-sattabacin, quantification of cytotoxicity and gene expression data in human fibroblast cells are also presented. Gene expression data was obtained through microarray analysis from human fibroblast cells exposed to sattabacin in order to identify a possible mechanism by which (+)-sattabacin inhibits VZV replication.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
References
-
- Lampis G; Deidda D; Maullu C; Madeddu MA; Pompei R; Monache FD; Satta GJ Antibiot. 1995, 48, 967. - PubMed
-
- Gnann JW Jr. Antiviral Therapy of Varicella-Zoster Virus Infections. In Human Herpesviruses: Biology, Therapy, and, Immunoprophylaxis; Arvin A, Campadelli-Fiume G, Mocarski E, Eds.; Cambridge University Press: Cambridge, 2007. Chapter 65. - PubMed
-
- Davis MM; Patel MS; Gebremariam A Pediatrics 2004, 114, 786. - PubMed
-
- Adverse Effects of Vaccines: Evidence and Causality; Stratton K, Ford A, Rusch E, Clayton EW, Eds.; The National Academies Press: Washington, DC, 2012. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
